Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment

• Egile Nagusiak: Yong Li (Egilea), Yiqun Li (Egilea), Dengke Li (Egilea), Kaiming Li (Egilea), Zhengyang Quan (Egilea), Ziyi Wang (Egilea), Zhenxiao Sun (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2020-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

BackgroundDrug repositioning, development of new uses for marketed drugs, is an effective way to discover new antitumor compounds. In this study, we used a new method, filtering compounds via molecular docking to find key targets combination.MethodsThe data of gene expression in cancer and normal ti...